INFORMED.
LIVE

Zenlabs Ethica Limited

BSE: ZENLABS530697ISIN INE546F01013
  • Services
  • Diversified Commercial Services

Share price

₹28.45-1.06 (-3.59%)
as of 18 Sep 2026
Zenlabs Ethica Limited share price, 18 Sep 2025 to 18 Sep 2026: ₹31.25 to ₹28.45 (-9.0%). Low ₹17.17, high ₹37.77. Volume shown below the price.
52W high
₹39.99
52W low
₹16.50
Off 52W high
-28.86%
1M return
+10.27%
3M return
-17.54%
6M return
+56.15%
1Y return
-8.96%
20D avg volume
3,600
50 DMA
₹29.08
200 DMA
₹25.72

Key ratios Standalone

Market cap
₹18.52 Cr
Current price
₹28.45
52W high / low
₹39.99 / ₹16.50
Face value
₹10.00
P/E
-7.29
P/B
1.80
EPS (TTM)
₹-3.90
Book value / share
₹15.81
ROE
-24.75%
ROCE
-9.90%
Operating margin
-2.05%
Net margin
-4.03%
Debt / equity
1.22
Net debt
₹7.52 Cr
Interest cover
-1.23
Dividend yield
Dividend / share (TTM)
Payout
Cash conversion cycle
119.2 days

Financials

MetricQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q4 FY24
Income statement
14.1810.5812.4312.4311.4812.99
0.000.120.000.060.000.04
14.7310.6212.3712.4211.4412.87
0.000.000.000.000.000.00
8.789.128.028.6410.128.05
0.451.061.041.041.041.03
0.160.180.230.190.210.23
0.110.140.230.240.290.31
0.482.251.581.551.602.59
-0.560.080.060.080.040.15
0.000.00-2.080.000.000.00
-0.560.08-2.010.080.040.15
0.020.08-0.010.040.010.06
-0.570.00-2.010.040.030.09
-0.880.00-3.080.060.050.14
Key metrics
-0.290.40-1.550.510.540.69
-2.00%3.80%-12.50%4.10%4.70%5.30%
-4.00%0.00%-16.20%0.30%0.30%0.70%
2.60%2.20%3.00%
23.50%-18.60%
-2,000.00%-100.00%
MetricTTMFY26FY25FY24
Income statement
49.6246.9251.42
0.180.180.05
50.1446.8451.04
0.000.000.00
34.5635.9138.33
3.594.174.20
0.760.810.93
0.720.891.26
5.866.977.43
-0.340.270.43
-2.08-2.080.00
-2.41-1.810.43
0.130.120.16
-2.54-1.940.27
-3.90-2.970.41
Key metrics
-0.93-0.112.62
-1.87%-0.20%5.10%
-5.12%-4.10%0.50%
-9.90%10.90%
-8.80%
-818.50%
4.063.83
-2.0914.19
1.221.14
7.5210.09
119.2130.3
Balance sheet
37.2140.62
35.1037.35
2.901.79
15.7019.54
15.0113.10
1.262.70
1.341.64
15.3914.28
27.1228.12
10.4211.88
10.2611.41
0.160.47
8.5110.43
Cash flow
4.063.83
0.000.14
-2.95-3.08
0.000.00

Compounded growth

Sales CAGR 3Y
Sales CAGR 5Y
Sales CAGR 10Y
Profit CAGR 3Y
Profit CAGR 5Y
Profit CAGR 10Y
Sales YoY (TTM)
Profit YoY (TTM)

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding
52.97%
HolderTypeHoldingPreviousChange
PREET REMEDIES LIMITEDPromoter26.58%
SANJAY DHIRPromoter13.18%
SANJEEV KUMAR SINGALPromoter13.17%
HITESH POPATLAL OSWALPublic6.79%
IEPF AUTHORITYPublic2.48%
B S MALLIKARJUNAPublic2.14%
BHASAKARRAI KANYALAL BHATTPublic1.86%
HARJINDER KAURPromoter Group0.02%
HIMJYOTIPromoter Group0.02%
DAMAN SINGHALPromoter Group0.00%
KULWANT KAURPromoter Group0.00%

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

Board meetings

  • Board Meeting - Financial Results